Allogene Archives -

A phase 1 trial of Allogene’s of-the-shelf CAR-T for lymphoma has been placed on hold by the FDA,

FDA halts Allogene CAR-T trial after safety scare

https://pharmaphorum.com/news/fda-halts-allogene-car-t-trial-after-safety-scare/

In 2018, the former leadership of team from Kite Pharma founded Allogene, on a mission to outdo the

Allogene set to disrupt CAR-T market with pivotal trial of ‘off the shelf’ therapy

https://pharmaphorum.com/news/allogene-announces-pivotal-trial/

Century Therapeutics has emerged from stealth mode to develop a new generation of ‘off the shelf’ cancer cell

Century gets $250m to develop next-gen ‘off the shelf’ cancer cell therapies

https://pharmaphorum.com/news/century-gets-250m-to-develop-next-gen-off-the-shelf-cancer-cell-therapies/

Startup biotech already raised $300m earlier this year

Allogene raises another $120m to develop ‘off-the-shelf’ CAR-Ts

https://pharmaphorum.com/news/allogene-raises-another-120m-to-develop-off-the-shelf-car-ts/

Belldegrun and Chang’s Allogene to take over from Pfizer in R&D deal

Ex-Kite chiefs’ biotech to research ‘off-the-shelf’ CAR-Ts with Cellectis

https://pharmaphorum.com/news/ex-kite-chiefs-biotech-research-off-shelf-car-ts-cellectis/

Allogene